Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.

Millares L, Pascual S, Montón C, García-Núñez M, Lalmolda C, Faner R, Casadevall C, Setó L, Capilla S, Moreno A, Castro-Acosta AA, Alvarez-Martinez CJ, Sibila O, Peces-Barba G, Cosio BG, Agustí A, Gea J, Monsó E.

BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.

2.

Nutritional abnormalities and chronic obstructive pulmonary disease.

Gea J, Barreiro E.

Int J Tuberc Lung Dis. 2019 May 1;23(5):531-532. doi: 10.5588/ijtld.19.0160. No abstract available.

PMID:
31097058
3.

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma.

Chalela R, Bellosillo B, Curull V, Longarón R, Pascual-Guardia S, Badenes-Bonet D, Arriola E, Sánchez-Font A, Pijuan L, Gea J.

J Clin Med. 2019 Apr 17;8(4). pii: E529. doi: 10.3390/jcm8040529.

4.

Endoplasmic reticulum stress and unfolded protein response in diaphragm muscle dysfunction of patients with stable chronic obstructive pulmonary disease.

Barreiro E, Salazar-Degracia A, Sancho-Muñoz A, Aguiló R, Rodríguez-Fuster A, Gea J.

J Appl Physiol (1985). 2019 Jun 1;126(6):1572-1586. doi: 10.1152/japplphysiol.00670.2018. Epub 2019 Apr 18.

PMID:
30998124
5.

ERS statement on respiratory muscle testing at rest and during exercise.

Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M, Dubé BP, Fauroux B, Gea J, Guenette JA, Hudson AL, Kabitz HJ, Laghi F, Langer D, Luo YM, Neder JA, O'Donnell D, Polkey MI, Rabinovich RA, Rossi A, Series F, Similowski T, Spengler CM, Vogiatzis I, Verges S.

Eur Respir J. 2019 Jun 13;53(6). pii: 1801214. doi: 10.1183/13993003.01214-2018. Print 2019 Jun.

PMID:
30956204
6.

Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation.

Marin-Corral J, Dot I, Boguña M, Cecchini L, Zapatero A, Gracia MP, Pascual-Guardia S, Vilà C, Castellví A, Pérez-Terán P, Gea J, Masclans JR.

Intensive Care Med. 2019 Apr;45(4):488-500. doi: 10.1007/s00134-019-05566-5. Epub 2019 Feb 21.

PMID:
30790029
7.

Is iron deficiency modulating physical activity in COPD?

Martín-Ontiyuelo C, Rodó-Pin A, Sancho-Muñoz A, Martinez-Llorens JM, Admetlló M, Molina L, Gea J, Barreiro E, Chiaradía DAR.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 11;14:211-214. doi: 10.2147/COPD.S182700. eCollection 2019.

8.

Endoplasmic reticulum stress and unfolded protein response profile in quadriceps of sarcopenic patients with respiratory diseases.

Barreiro E, Salazar-Degracia A, Sancho-Muñoz A, Gea J.

J Cell Physiol. 2019 Jul;234(7):11315-11329. doi: 10.1002/jcp.27789. Epub 2018 Nov 22.

PMID:
30565689
9.

Differences in micro-RNA expression profile between vastus lateralis samples and myotubes in COPD cachexia.

Barreiro E, Sancho-Muñoz A, Puig-Vilanova E, Salazar-Degracia A, Pascual-Guardia S, Casadevall C, Gea J.

J Appl Physiol (1985). 2019 Feb 1;126(2):403-412. doi: 10.1152/japplphysiol.00611.2018. Epub 2018 Dec 13.

PMID:
30543501
10.

Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease.

Demeyer H, Donaire-Gonzalez D, Gimeno-Santos E, Ramon MA, DE Battle J, Benet M, Serra I, Guerra S, Farrero E, Rodriguez E, Ferrer J, Sauleda J, Monso E, Gea J, Rodriguez-Roisin R, Agusti A, Antó JM, Garcia-Aymerich J.

Med Sci Sports Exerc. 2019 May;51(5):833-840. doi: 10.1249/MSS.0000000000001859.

PMID:
30531289
11.

Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, Caobelli F, Lococo F, Gea J, Sancho-Muñoz A, Schildt J, Tatcı E, Lapa C, Keramida G, Peters M, Boktor RR, John J, Pitman AG, Mazurek T, Rezaei N.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):224-237. doi: 10.1007/s00259-018-4194-x. Epub 2018 Oct 22.

PMID:
30350009
12.

The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.

Gea J, Pascual S, Castro-Acosta A, Hernández-Carcereny C, Castelo R, Márquez-Martín E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosío BG, Agustí A; en representación del grupo BIOMEPOC; Anexo. Miembros del grupo BIOMEPOC.

Arch Bronconeumol. 2019 Feb;55(2):93-99. doi: 10.1016/j.arbres.2018.07.026. Epub 2018 Oct 19. English, Spanish.

13.

Teaching by example: Who teaches Respiratory Medicine in medical schools?

Casan Clarà P, Barrueco Ferrero M, Gea J; en representación del Comité de Pregrado de SEPAR.

Arch Bronconeumol. 2019 May;55(5):231-232. doi: 10.1016/j.arbres.2018.07.009. Epub 2018 Oct 9. English, Spanish. No abstract available.

14.

Bispectral index in hypercapnic encephalopathy associated with COPD exacerbation: a pilot study.

Chalela R, Gallart L, Pascual-Guardia S, Sancho-Muñoz A, Gea J, Orozco-Levi M.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 26;13:2961. doi: 10.2147/COPD.S167020. eCollection 2018.

15.

Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: Latest Developments.

Gea J, Martínez-Llorens J.

Arch Bronconeumol. 2019 May;55(5):237-238. doi: 10.1016/j.arbres.2018.07.016. Epub 2018 Oct 5. English, Spanish. No abstract available.

16.

Rectal, central venous, gastric and bladder pressures versus esophageal pressure for the measurement of cough strength: a prospective clinical comparison.

Aguilera LG, Gallart L, Álvarez JC, Vallès J, Gea J.

Respir Res. 2018 Oct 1;19(1):191. doi: 10.1186/s12931-018-0897-6.

17.

Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy.

Chalela R, Gea J, Barreiro E.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2186-S2189. doi: 10.21037/jtd.2018.06.143. No abstract available.

18.

Nutritional Abnormalities And Muscle Dysfunction In Idiopathic Pulmonary Fibrosis.

Gea J, Bàdenes D, Balcells E.

Arch Bronconeumol. 2018 Nov;54(11):545-546. doi: 10.1016/j.arbres.2018.04.008. Epub 2018 Jun 19. English, Spanish. No abstract available.

19.

Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Gea J, Sancho-Muñoz A, Chalela R.

J Thorac Dis. 2018 May;10(Suppl 12):S1332-S1354. doi: 10.21037/jtd.2018.02.66. Review.

20.

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.

Estirado C, Ceccato A, Guerrero M, Huerta A, Cilloniz C, Vilaró O, Gabarrús A, Gea J, Crisafulli E, Soler N, Torres A.

Respir Res. 2018 Jun 15;19(1):119. doi: 10.1186/s12931-018-0820-1.

21.

The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia.

Barreiro E, Puig-Vilanova E, Salazar-Degracia A, Pascual-Guardia S, Casadevall C, Gea J.

J Appl Physiol (1985). 2018 Aug 1;125(2):287-303. doi: 10.1152/japplphysiol.00798.2017. Epub 2018 Apr 12.

22.

Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice.

Soler-Cataluña JJ, Puente Maestu L, Román-Rodríguez M, Esteban C, Gea J, Bernabeu Mora R, Pleguezuelos Cobo E, Ancochea J, Monteagudo Ruiz G, Garcia Rio F.

Arch Bronconeumol. 2018 Sep;54(9):467-475. doi: 10.1016/j.arbres.2018.01.016. Epub 2018 Mar 13. English, Spanish.

23.

Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions.

Mateu-Jimenez M, Curull V, Rodríguez-Fuster A, Aguiló R, Sánchez-Font A, Pijuan L, Gea J, Barreiro E.

Clin Epigenetics. 2018 Jan 16;10:7. doi: 10.1186/s13148-017-0437-0. eCollection 2018.

24.

Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia.

Izquierdo-Garcia JL, Nin N, Jimenez-Clemente J, Horcajada JP, Arenas-Miras MDM, Gea J, Esteban A, Ruiz-Cabello J, Lorente JA.

Shock. 2018 Nov;50(5):504-510. doi: 10.1097/SHK.0000000000001099.

PMID:
29293175
25.

The Future of Biological Therapies in COPD.

Gea J.

Arch Bronconeumol. 2018 Apr;54(4):185-186. doi: 10.1016/j.arbres.2017.11.004. Epub 2017 Dec 29. English, Spanish. No abstract available.

26.

Increased Urinary Erythropoietin Excretion in Severe Sleep Apnea-Hipoapnea Syndrome: The Effect of CPAP.

Félez M, Grau N, Ruiz A, Guardiola E, Sanjuas C, Estirado C, Navarro-Muñoz M, Pascual A, Orozco-Levi M, Gea J.

Arch Bronconeumol. 2018 May;54(5):255-259. doi: 10.1016/j.arbres.2017.10.013. Epub 2017 Dec 6. English, Spanish.

27.

PARP-1 and PARP-2 activity in cancer-induced cachexia: potential therapeutic implications.

Barreiro E, Gea J.

Biol Chem. 2018 Jan 26;399(2):179-186. doi: 10.1515/hsz-2017-0158. Review.

PMID:
29016348
28.

Characterization of ancient lipids in prehistoric organic residues: Chemical evidence of livestock-pens in rock-shelters since early neolithic to bronze age.

Gea J, Sampedro MC, Vallejo A, Polo-Díaz A, Goicolea MA, Fernández-Eraso J, Barrio RJ.

J Sep Sci. 2017 Dec;40(23):4549-4562. doi: 10.1002/jssc.201700692. Epub 2017 Nov 3.

PMID:
28988466
29.

Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.

30.

Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Chalela R, Curull V, Enríquez C, Pijuan L, Bellosillo B, Gea J.

J Thorac Dis. 2017 Jul;9(7):2142-2158. doi: 10.21037/jtd.2017.06.20. Review.

31.

Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform.

Ferrarini A, Righetti L, Martínez MP, Fernández-López M, Mastrangelo A, Horcajada JP, Betbesé A, Esteban A, Ordóñez J, Gea J, Cabello JR, Pellati F, Lorente JA, Nin N, Rupérez FJ.

Electrophoresis. 2017 Sep;38(18):2341-2348. doi: 10.1002/elps.201700112. Epub 2017 Aug 25.

PMID:
28714069
32.

Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures.

Pascual-Guardia S, Badenes-Bonet D, Martin-Ontiyuelo C, Zuccarino F, Marín-Corral J, Rodríguez A, Barreiro E, Gea J.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 21;12:1837-1845. doi: 10.2147/COPD.S129213. eCollection 2017.

33.

Inspiratory muscle activation increases with COPD severity as confirmed by non-invasive mechanomyographic analysis.

Sarlabous L, Torres A, Fiz JA, Martínez-Llorens JM, Gea J, Jané R.

PLoS One. 2017 May 18;12(5):e0177730. doi: 10.1371/journal.pone.0177730. eCollection 2017.

34.

Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Gea J, Casadevall C, Pascual S, Orozco-Levi M, Barreiro E.

J Thorac Dis. 2016 Nov;8(11):3379-3400. doi: 10.21037/jtd.2016.11.105. Review.

35.

Level of daily physical activity in chronic obstructive pulmonary disease (COPD) patients according to GOLD classification.

Rodó-Pin A, Balañá A, Molina L, Gea J, Rodríguez DA.

Med Clin (Barc). 2017 Feb 9;148(3):114-117. doi: 10.1016/j.medcli.2016.10.036. Epub 2016 Dec 16. English, Spanish.

PMID:
27993404
36.

Right Ventricular Response During Exercise in Patients with Chronic Obstructive Pulmonary Disease.

Rodríguez DA, Sancho-Muñoz A, Rodó-Pin A, Herranz A, Gea J, Bruguera J, Molina L.

Heart Lung Circ. 2017 Jun;26(6):631-634. doi: 10.1016/j.hlc.2016.10.015. Epub 2016 Nov 30.

PMID:
27988278
37.

Software project management tools in global software development: a systematic mapping study.

Chadli SY, Idri A, Ros JN, Fernández-Alemán JL, de Gea JM, Toval A.

Springerplus. 2016 Nov 24;5(1):2006. eCollection 2016.

38.

Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.

Ausín P, Martínez-Llorens J, Sabaté-Bresco M, Casadevall C, Barreiro E, Gea J.

Chron Respir Dis. 2017 May;14(2):127-139. doi: 10.1177/1479972316674412. Epub 2016 Dec 6.

39.

Head movement measurement: An alternative method for posturography studies.

Ciria LF, Muñoz MA, Gea J, Peña N, Miranda JGV, Montoya P, Vila J.

Gait Posture. 2017 Feb;52:100-106. doi: 10.1016/j.gaitpost.2016.11.020. Epub 2016 Nov 17. Review.

PMID:
27888694
40.

Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Barreiro E, Bustamante V, Curull V, Gea J, López-Campos JL, Muñoz X.

J Thorac Dis. 2016 Oct;8(10):E1122-E1135. Review.

41.

Prospective validation of right ventricular role in primary graft dysfunction after lung transplantation.

Pérez-Terán P, Roca O, Rodríguez-Palomares J, Ruiz-Rodríguez JC, Zapatero A, Gea J, Serra J, Evangelista A, Masclans JR.

Eur Respir J. 2016 Dec;48(6):1732-1742. doi: 10.1183/13993003.02136-2015. Epub 2016 Oct 6.

42.

Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease.

Mateu-Jimenez M, Curull V, Pijuan L, Sánchez-Font A, Rivera-Ramos H, Rodríguez-Fuster A, Aguiló R, Gea J, Barreiro E.

J Thorac Oncol. 2017 Feb;12(2):235-248. doi: 10.1016/j.jtho.2016.09.137. Epub 2016 Oct 25.

43.

Time-Course of Muscle Mass Loss, Damage, and Proteolysis in Gastrocnemius following Unloading and Reloading: Implications in Chronic Diseases.

Chacon-Cabrera A, Lund-Palau H, Gea J, Barreiro E.

PLoS One. 2016 Oct 28;11(10):e0164951. doi: 10.1371/journal.pone.0164951. eCollection 2016.

44.

Short- and Long-Term Hindlimb Immobilization and Reloading: Profile of Epigenetic Events in Gastrocnemius.

Chacon-Cabrera A, Gea J, Barreiro E.

J Cell Physiol. 2017 Jun;232(6):1415-1427. doi: 10.1002/jcp.25635. Epub 2016 Oct 19.

PMID:
27714819
45.

Inflammatory Events and Oxidant Production in the Diaphragm, Gastrocnemius, and Blood of Rats Exposed to Chronic Intermittent Hypoxia: Therapeutic Strategies.

Domínguez-Álvarez M, Gea J, Barreiro E.

J Cell Physiol. 2017 May;232(5):1165-1175. doi: 10.1002/jcp.25600. Epub 2016 Sep 30.

PMID:
27635524
46.

Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations.

Chalela R, González-García JG, Chillarón JJ, Valera-Hernández L, Montoya-Rangel C, Badenes D, Mojal S, Gea J.

Respir Med. 2016 Aug;117:237-42. doi: 10.1016/j.rmed.2016.05.003. Epub 2016 Jun 29.

47.

Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.

Cosío BG, Shafiek H, Iglesias A, Yanez A, Córdova R, Palou A, Rodriguez-Roisin R, Peces-Barba G, Pascual S, Gea J, Sibila O, Barnes PJ, Agusti A.

Chest. 2016 Jul;150(1):123-30. doi: 10.1016/j.chest.2016.04.011. Epub 2016 Apr 21.

PMID:
27107490
48.

Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Barreiro E, Gea J.

Chron Respir Dis. 2016 Aug;13(3):297-311. doi: 10.1177/1479972316642366. Epub 2016 Apr 6. Review.

49.

The prognostic value of muscle regional oxygen saturation index in severe community-acquired pneumonia: a prospective observational study.

Claverias L, Marí M, Marín-Corral J, Magret M, Trefler S, Bodí M, García-España A, Yébenes JC, Pascual S, Gea J, Rodríguez A.

J Intensive Care. 2016 Jan 19;4:7. doi: 10.1186/s40560-016-0129-4. eCollection 2016.

50.

Redox Imbalance in Lung Cancer of Patients with Underlying Chronic Respiratory Conditions.

Mateu-Jiménez M, Sánchez-Font A, Rodríguez-Fuster A, Aguilό R, Pijuan L, Fermoselle C, Gea J, Curull V, Barreiro E.

Mol Med. 2016 Sep;22:85-98. doi: 10.2119/molmed.2015.00199. Epub 2016 Jan 7.

Supplemental Content

Support Center